M1030 – Patients with clinical indications for imaging of the head

Long description

Patients with clinical indications for imaging of the head

Short description

Pt clin ind img hd

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2019

Last change

January 1, 2020 – No change

Termination date

December 31, 2019

Nearby M codes

• M1022 – Patients who were in hospice at any time during the performance period
• M1023 – Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five
• M1024 – Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five
• M1025 – Patients who were in hospice at any time during the performance period
• M1026 – Patients who were in hospice at any time during the performance period
• M1027 – Imaging of the head (ct or mri) was obtained
• M1028 – Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
• M1029 – Imaging of the head (ct or mri) was not obtained, reason not given
• M1031 – Patients with no clinical indications for imaging of the head
• M1032 – Adults currently taking pharmacotherapy for oud
• M1033 – Pharmacotherapy for oud initiated after june 30th of performance period
• M1034 – Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
• M1035 – Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
• M1036 – Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
• M1037 – Patients with a diagnosis of lumbar spine region cancer at the time of the procedure
• M1038 – Patients with a diagnosis of lumbar spine region fracture at the time of the procedure